December 26, 2023 Pulse Biosciences, Inc., a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter. All patients were successfully discharged by treating physicians. Patients will continue to be monitored and evaluated over the coming months to assess safety and effectiveness with the primary safety endpoint at 30 days.
Dr. Vivek Reddy, Director of Cardiac Arrhythmia Services at Mount Sinai Hospital, NY, and Dr. Petr Neuzil, Chief of Cardiology at Na Homolce Hospital, Prague, and colleagues used the Companys CellFX nsPFA 360 cardiac catheter integrated with 3D mapping and navigation technologies (iMap System, CardioNXT) to successfully treat five patients with atrial fibrillation (AF) at Na Homolce Hospital, a renowned research institution hospital in Prague, Czech Republic.
We have been collaborating with Pulse Biosciences to bring their novel nsPFA technology to the clinical realm, and are excited to report that our experience with these first five patients has validated our belief that this may represent the next generation of PFA technology for the treatment of AF, said Dr. Reddy. The results were consistent with our preclinical experience. Importantly, the speed and ease with which we were able to isolate the pulmonary veins with the nsPFA 360 catheter was impressive and all patients tolerated the procedure well. Now we look forward to completing enrollment in this study to fully assess the safety and durability of nsPFA treatment.
Pulse Biosciences CellFX nsPFA 360 cardiac catheter, which is still in the investigational stage, is uniquely designed to produce a nonthermal ablation, initially targeted for pulmonary vein isolation, using the Companys proprietary CellFX nsPFA energy in the treatment of atrial fibrillation. The catheter is designed to deliver a fast, transmural and fully circumferential ablation in a single energy delivery. The CellFX nsPFA cardiac catheter is integrated with 3D mapping and navigation to deliver a comprehensive visualization and precise ablation delivery solution.
Were honored to work with Dr. Reddy and his team and Prof. Petr Neuzil and his team at Na Homolce to bring our next generation nsPFA technology to the clinic. The unique value of nsPFA to deliver fast, precise, transmural and contiguous ablations in thick cardiac tissue is extremely exciting for the treatment of AF and we could not have found better partners, said Dr. Gan Dunnington, Chief Medical Officer, Cardiac Surgery of Pulse Biosciences. This initial clinical experience delivered as expected. We look forward to continuing our catheter clinical program and to starting our cardiac surgery clinical program with our surgical nsPFA clamp in 2024.
Kevin Danahy, President and CEO of Pulse Biosciences, having attended all patient cases, remarked on the recent milestone, As we embark on this new era of advancement in medical device technology, our mission is clear: to revolutionize healthcare with CellFX nsPFA, with the intention of significantly improving clinical outcomes for both patients and physicians. Through relentless innovation, unwavering dedication, and commitment to pushing the boundaries of what is possible in bioelectric energy, we are reshaping the future of the treatment for atrial fibrillation with our cardiac catheter in electrophysiology and with our cardiac clamp in cardiothoracic surgery. CellFX nsPFA will empower doctors, inspire patients to seek life-altering treatment, and create a world where CellFX nsPFA technology can become a catalyst for healing and hope.
The Company expects to enroll up to a total of 30 patients in the current feasibility study. Treated patients will be evaluated at regular intervals to further assess the safety and effectiveness of the treatments. The Company expects to provide additional updates on the first-in-human procedures with the CellFX system in the upcoming months. Pulse Biosciences will inform stakeholders promptly if results differ materially from the stated expectations addressing safety and efficacy. The observations to date have been positive but the broad set of risks associated with cardiac surgery remain. The Company anticipates initiating the regulatory process with the U.S. FDA and appropriate regulatory authorities worldwide including Europe in the coming quarters and expects additional studies will be required.
For more information: http://www.pulsebiosciences.com
See the article here:
- Capital Cardiology Associates and CDPHP at odds over withheld payments - Times Union - March 30th, 2025 [March 30th, 2025]
- Mar 28, 2025 This Week in Cardiology Podcast - Medscape - March 30th, 2025 [March 30th, 2025]
- Green Spaces and Heart Health: A Natural Connection - The Cardiology Advisor - March 30th, 2025 [March 30th, 2025]
- Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting - Business Wire - March 30th, 2025 [March 30th, 2025]
- SA Asks: What are the best large-cap cardiology stocks right now? - Seeking Alpha - March 30th, 2025 [March 30th, 2025]
- Introducing New Cardiology Members - University of Utah School of Medicine - March 30th, 2025 [March 30th, 2025]
- SA Asks: Which cardiology drug companies could be takeout candidates? - Seeking Alpha - March 30th, 2025 [March 30th, 2025]
- Teams at Stormont Vail Hospital heard firsthand from a leading expert and researcher in cardiology - WIBW - March 30th, 2025 [March 30th, 2025]
- ACC 2025: GE HealthCare announces the U.S. launch of pivotal innovations that will help transform the cardiology care pathway - Business Wire - March 30th, 2025 [March 30th, 2025]
- CONNEQT Health Launches Industry-First Cardiology Report to Bring Clinical Heart Health Insights Home - Fitt Insider - March 30th, 2025 [March 30th, 2025]
- Indian Cardiology Market Size Trends and Forecast by Application, Type, and Geography, Opportunity Analysis - openPR - March 30th, 2025 [March 30th, 2025]
- What are the Health Benefits of the DASH Diet Plan? - Cardiology - Health Matters - March 15th, 2025 [March 15th, 2025]
- Mar 14, 2025 This Week in Cardiology Podcast - Medscape - March 15th, 2025 [March 15th, 2025]
- ECU Health offers remote healthcare access for cardiology patients - WNCT - March 15th, 2025 [March 15th, 2025]
- Powers Health cardiology experts support Hearts of Hope campaign, explore innovative treatments to improve patient lives at free community event -... - March 15th, 2025 [March 15th, 2025]
- Cardiology groups urge Congress to take a stand after spending proposal fails to fix Medicare cuts - Cardiovascular Business - March 15th, 2025 [March 15th, 2025]
- Rivus Pharmaceuticals Announces Publication of Phase 2a HuMAIN Trial of HU6 in Patients with Obesity-Related Heart Failure in JAMA Cardiology - PR... - March 15th, 2025 [March 15th, 2025]
- Broward Health Adds Pulsed Field Ablation Sytsem to Treat A-fib - Diagnostic and Interventional Cardiology - March 15th, 2025 [March 15th, 2025]
- Global Interventional Cardiology Devices Market Poised for Remarkable Growth, Set to Reach USD 36.9 Billion by 2032 | FMI FMIBlog - Future Market... - March 5th, 2025 [March 5th, 2025]
- MCCH earns cath lab accreditation by the American College of Cardiology - The Trib - March 5th, 2025 [March 5th, 2025]
- Feb 28, 2025 This Week in Cardiology Podcast - Medscape - March 5th, 2025 [March 5th, 2025]
- Ozempic and other GLP-1s are trending in Hollywood and cardiology departments - WGLT - March 5th, 2025 [March 5th, 2025]
- Detecting coronary inflammation on CT imaging could reshape preventive cardiology - Cardiovascular Business - March 5th, 2025 [March 5th, 2025]
- Global Surge in Heart Rhythm Disorders Sparks Call to Action - Diagnostic and Interventional Cardiology - March 5th, 2025 [March 5th, 2025]
- Fujifilm Expands Partnership with Hackensack Meridian Health Enabling Network-wide Use of State-of-the-Art Synapse Cardiology PACS Imaging System -... - March 5th, 2025 [March 5th, 2025]
- Behind the Walls of Cardiology: Where innovation meets compassion - Brunswick News - February 25th, 2025 [February 25th, 2025]
- Cardiology Team: Making a Difference in Your Heart - Southeast Georgia Health System - February 25th, 2025 [February 25th, 2025]
- Feb 21, 2025 This Week in Cardiology Podcast - Medscape - February 25th, 2025 [February 25th, 2025]
- Nuclear cardiology a nuclear perspective on matters of the heart - healthcare-in-europe.com - February 25th, 2025 [February 25th, 2025]
- Ionis Continues to Expand Its Cardiology and Neurology Portfolio, Supporting Narrow Moat - Morningstar - February 25th, 2025 [February 25th, 2025]
- Shenango Cardiology Consultants Affiliates with Meadville Medical - businessjournaldaily.com - February 25th, 2025 [February 25th, 2025]
- Author balances romance writing with cardiology insights - Turn to 10 - February 25th, 2025 [February 25th, 2025]
- Providing Health Care in Conflict Zones: A Neurosurgeons Mission to Gaza - The Cardiology Advisor - February 3rd, 2025 [February 3rd, 2025]
- Jan 31, 2025 This Week in Cardiology Podcast - Medscape - February 3rd, 2025 [February 3rd, 2025]
- At Least 60% of Americans To Have Heart Disease By 2050, According To Alarming Study Cardiology Experts Offer Tips To Know This Heart Month -... - February 3rd, 2025 [February 3rd, 2025]
- FMC column: Prioritize preventative cardiology during American Heart Month in February - Lancaster Eagle Gazette - February 3rd, 2025 [February 3rd, 2025]
- Interventional Cardiology Joins The Match for First Time - Medscape - January 23rd, 2025 [January 23rd, 2025]
- Akron Childrens teams with Cincinnati Childrens on pediatric cardiology care - Crain's Cleveland Business - January 23rd, 2025 [January 23rd, 2025]
- FDA regulator examines AI's growing influence in cardiology - Cardiovascular Business - January 23rd, 2025 [January 23rd, 2025]
- Jan 17, 2025 This Week in Cardiology Podcast - Medscape - January 23rd, 2025 [January 23rd, 2025]
- Jan 10, 2025 This Week in Cardiology Podcast - Medscape - January 15th, 2025 [January 15th, 2025]
- UC Davis Health cardiology team is one of the first in the nation to use novel pVAD system - UC Davis Health - January 15th, 2025 [January 15th, 2025]
- Bethesda Health Clinic Receives $15,000 Grant from American Heart Associations Circle of Red to Enhance Cardiology Services - Gilmer Mirror - January 15th, 2025 [January 15th, 2025]
- Top in cardiology: Antipsychotic drugs prolong severe QT; intermittent fasting and death - Healio - January 1st, 2025 [January 1st, 2025]
- ICYMI: 'Exploding in population': Nampa hospital expansion to bring needed NICU, cardiology space - boisedev.com - January 1st, 2025 [January 1st, 2025]
- Dec 20, 2024 This Week in Cardiology Podcast - Medscape - December 23rd, 2024 [December 23rd, 2024]
- Samuel Family Cardiology to open medical office in Spring - Community Impact - December 23rd, 2024 [December 23rd, 2024]
- Top in cardiology: Impact of added sugar source on CVD risk; SGLT2, GLP-1 use after stroke - Healio - December 23rd, 2024 [December 23rd, 2024]
- Researchers Find Drinking Coffee May Help Prevent Mental Decline in People with AFib - Diagnostic and Interventional Cardiology - December 23rd, 2024 [December 23rd, 2024]
- Narrow-Moat Ionis Is Expanding Its Neurology and Cardiology Portfolio to Strengthen Its Moat - Morningstar - December 9th, 2024 [December 9th, 2024]
- Shaping the Future of Cardiology: Key Takeaways From AHA 2024 - AJMC.com Managed Markets Network - November 28th, 2024 [November 28th, 2024]
- Jennifer DuMond Joins Cardiology Associates of Schenectady - SPHP News - November 28th, 2024 [November 28th, 2024]
- Nov 22, 2024 This Week in Cardiology Podcast - Medscape - November 28th, 2024 [November 28th, 2024]
- Fujifilm to Highlight the Speed of Synapse VX for Mammography and Cardiology, Cloud-Native Architecture and AI-Driven Workflows at RSNA 2024 - The... - November 28th, 2024 [November 28th, 2024]
- Director of Cardiology Research and Practical Centre: in many respects we keep pace with worlds largest clinics - - - November 28th, 2024 [November 28th, 2024]
- AI breakthrough in healthcare to revolutionize cardiology and more - Eyewitness News 3 - November 20th, 2024 [November 20th, 2024]
- Lehigh Valley Heart and Vascular Institute Welcomes Two Cardiology Specialists - Lehigh Valley Health Network - November 20th, 2024 [November 20th, 2024]
- Nov 15, 2024 This Week in Cardiology Podcast - Medscape - November 20th, 2024 [November 20th, 2024]
- Noblestitch Suture-Mediated PFO Closure Yields Zero Recurrent Strokes in the largest cohort with Four-Year Study presented at the TCT cardiology... - November 20th, 2024 [November 20th, 2024]
- Centra Health shifting cardiology services from Danville to Gretna - GoDanRiver.com - November 20th, 2024 [November 20th, 2024]
- Interventional Cardiology Devices Market to Reach $33.46 Billion by 2031, Growing at a 7.5% CAGR As Reveale... - WhaTech - November 20th, 2024 [November 20th, 2024]
- Dr. Kathleen A. Harper, MD is featured as a TOP INDUSTRY EXPERT Representing the Field of Cardiology for 2024 - EIN News - November 20th, 2024 [November 20th, 2024]
- 'Exploding in population': Nampa hospital expansion to bring needed NICU, cardiology space - boisedev.com - November 12th, 2024 [November 12th, 2024]
- Cardiology Diagnostics Market: Rapid Growth and Key Research - openPR - November 12th, 2024 [November 12th, 2024]
- Oct 25, 2024 This Week in Cardiology Podcast - Medscape - October 26th, 2024 [October 26th, 2024]
- Cardiology of Virginia patient data appears to be up for sale. Has the entity issued any statement at all? - DataBreaches.net - October 26th, 2024 [October 26th, 2024]
- Philips showcases next level cardiology innovations for improved patient care at TCT 2024 - Yahoo Finance - October 26th, 2024 [October 26th, 2024]
- Care Medical and Boston Scientific to enhance cardiology and urology care - Healthcare Asia - October 26th, 2024 [October 26th, 2024]
- Is Cardiology Overtreating Aortic Stenosis? with Linda Gillam, MD, MPH - MD Magazine - October 13th, 2024 [October 13th, 2024]
- Oct 11, 2024 This Week in Cardiology Podcast - Medscape - October 13th, 2024 [October 13th, 2024]
- The need for a personalized implementation hypertension strategy to facilitate the implementation of the new European Society of Hypertension (2023),... - October 13th, 2024 [October 13th, 2024]
- Cardiology Information System Market Size Expected To Grow At Around 8.6% CAGR During The Forecast Period - openPR - October 2nd, 2024 [October 2nd, 2024]
- OSF Medical Group in Alton Welcomes Second Cardiology Nurse Practitioner Mary Goetten - RiverBender.com - October 2nd, 2024 [October 2nd, 2024]
- Top in cardiology: Heart attacks spike after cold spells; Wegovy linked to CV benefits - Healio - October 2nd, 2024 [October 2nd, 2024]
- The Potential Risks of Lecanemab Use in Patients With High Cardiovascular Risk - The Cardiology Advisor - October 2nd, 2024 [October 2nd, 2024]
- $41,900.3+ Mn Interventional Cardiology and Peripheral Vascular Devices Market: Rising Demand and Growth - EIN News - October 2nd, 2024 [October 2nd, 2024]
- Central Pa. cardiology practice relocates one of its offices - PennLive - October 2nd, 2024 [October 2nd, 2024]
- Emerging Therapies in Interventional Cardiology - ETHealthWorld - October 2nd, 2024 [October 2nd, 2024]
- Sep 20, 2024 This Week in Cardiology Podcast - Medscape - September 23rd, 2024 [September 23rd, 2024]
- 'An exciting time': PCB medical office building adds cardiology and pulmonary services - The News Herald - September 23rd, 2024 [September 23rd, 2024]